BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17694226)

  • 1. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
    Borucki K; Töpfer G; Hartung KJ; Lutze G
    Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
    Wiwanitkit V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor to factor V in severe factor V congenital deficiency. A case report.
    Mazzucconi MG; Solinas S; Chistolini A; Motta M; Mariani G
    Nouv Rev Fr Hematol (1978); 1985; 27(5):303-5. PubMed ID: 4080539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of an asymptomatic idiopathic inhibitor to coagulation factor V.
    Lucia JF; Aguilar C
    Haemophilia; 2005 Mar; 11(2):178-80. PubMed ID: 15810922
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of factor V deficiency presenting as menorrhagia.
    Sapuri M; Amoa AB; Kariwiga G; White J
    P N G Med J; 1997 Jun; 40(2):92-5. PubMed ID: 10513230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired factor V inhibitor in a critically ill patient.
    Morris CJ; Curry N
    Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.
    Cmolik BL; Spero JA; Magovern GJ; Clark RE
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):222-7; discussion 227-8. PubMed ID: 8429648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired inhibitors of factor V.
    Feinstein DI
    Thromb Haemost; 1978 Jun; 39(3):663-74. PubMed ID: 705695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary combined coagulation factor V and factor VIII deficiency: report of two Indian families from Varanasi.
    Shukla J; Singhal R; Garbyal RS; Singh VP; Dube B
    Indian J Pathol Microbiol; 2002 Apr; 45(2):151-4. PubMed ID: 12696729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays.
    Perdekamp MT; Rubenstein DA; Jesty J; Hultin MB
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):593-7. PubMed ID: 16988558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality therapy of an acquired factor V inhibitor.
    Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
    Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer.
    Caers J; Reekmans A; Jochmans K; Naegels S; Mana F; Urbain D; Reynaert H
    Endoscopy; 2003 Jun; 35(6):542-4. PubMed ID: 12783357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited and acquired factor V deficiency.
    Lippi G; Favaloro EJ; Montagnana M; Manzato F; Guidi GC; Franchini M
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):160-6. PubMed ID: 21245750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases.
    Poynton AR; Nelson MC; McCance SE; Levine RL; O'Leary PF
    Spine (Phila Pa 1976); 2003 Jun; 28(12):E221-3. PubMed ID: 12811284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin].
    Miesbach W; Voigt J; Peetz D; Scharrer I
    Med Klin (Munich); 2003 Jun; 98(6):339-43. PubMed ID: 12811419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
    de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
    Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of plasma exchange in hereditary deficiency of factor V and factor VIII.
    Sallah AS; Angchaisuksiri P; Roberts HR
    Am J Hematol; 1996 Jul; 52(3):229-30. PubMed ID: 8756096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in understanding the bleeding diathesis in factor V deficiency.
    Duckers C; Simioni P; Rosing J; Castoldi E
    Br J Haematol; 2009 Jun; 146(1):17-26. PubMed ID: 19438479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of an acquired inhibitor to coagulation factor V.
    Shanmugam H; Jayaranee S; Eow GI
    Haemophilia; 2011 Jan; 17(1):168-70. PubMed ID: 20557356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.